These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10485365)

  • 1. Pharmacology of anthelmintic resistance in cyathostomes: will it occur with the avermectin/milbemycins?
    Sangster NC
    Vet Parasitol; 1999 Aug; 85(2-3):189-201; discussion 201-4, 215-25. PubMed ID: 10485365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to avermectin/milbemycin anthelmintics in equine cyathostomins - current situation.
    Molento MB; Nielsen MK; Kaplan RM
    Vet Parasitol; 2012 Apr; 185(1):16-24. PubMed ID: 22047763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The persistence of benzimidazole-resistant cyathostomes on horse farms in Ontario over 10 years and the effectiveness of ivermectin and moxidectin against these resistant strains.
    Slocombe JO; Coté JF; de Gannes RV
    Can Vet J; 2008 Jan; 49(1):56-60. PubMed ID: 18320979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazole resistance in equine cyathostomes in Slovakia.
    Várady M; Königová A; Corba J
    Vet Parasitol; 2000 Dec; 94(1-2):67-74. PubMed ID: 11078945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasite diversity and anthelmintic resistance in two herds of horses.
    Young KE; Garza V; Snowden K; Dobson RJ; Powell D; Craig TM
    Vet Parasitol; 1999 Aug; 85(2-3):205-14; discussion 215-25. PubMed ID: 10485366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthelmintic resistance in nematodes of horses.
    Kaplan RM
    Vet Res; 2002; 33(5):491-507. PubMed ID: 12387486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortened egg reappearance periods of equine cyathostomins following ivermectin or moxidectin treatment: morphological and molecular investigation of efficacy and species composition.
    Nielsen MK; Steuer AE; Anderson HP; Gavriliuc S; Carpenter AB; Redman EM; Gilleard JS; Reinemeyer CR; Poissant J
    Int J Parasitol; 2022 Nov; 52(12):787-798. PubMed ID: 36244428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tests for anthelmintic resistance in cyathostomes.
    Pook JF; Power ML; Sangster NC; Hodgson JL; Hodgson DR
    Vet Parasitol; 2002 Jul; 106(4):331-43. PubMed ID: 12079739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthelmintic therapy of equine cyathostomin nematodes - larvicidal efficacy, egg reappearance period, and drug resistance.
    Bellaw JL; Krebs K; Reinemeyer CR; Norris JK; Scare JA; Pagano S; Nielsen MK
    Int J Parasitol; 2018 Feb; 48(2):97-105. PubMed ID: 29050919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of moxidectin with ivermectin and pyrantel embonate for reduction of faecal egg counts in horses.
    Taylor SM; Kenny J
    Vet Rec; 1995 Nov; 137(20):516-8. PubMed ID: 8588278
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyathostomes in horses in Canada resistant to pyrantel salts and effectively removed by moxidectin.
    Slocombe JO; de Gannes RV
    Vet Parasitol; 2006 Aug; 140(1-2):181-4. PubMed ID: 16682123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthelmintic treatment in horses: the extra-label use of products and the danger of under-dosing.
    Matthee S
    J S Afr Vet Assoc; 2003 Jun; 74(2):53-6. PubMed ID: 12967052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of moxidectin oral gel in horses.
    DiPietro JA; Hutchens DE; Lock TF; Walker K; Paul AJ; Shipley C; Rulli D
    Vet Parasitol; 1997 Oct; 72(2):167-77. PubMed ID: 9404843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of ivermectin efficacy against cyathostomins and Parascaris equorum on horse farms using selective therapy.
    Larsen ML; Ritz C; Petersen SL; Nielsen MK
    Vet J; 2011 Apr; 188(1):44-7. PubMed ID: 20385508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study to evaluate the field efficacy of ivermectin, fenbendazole and pyrantel pamoate, with preliminary observations on the efficacy of doramectin, as anthelmintics in horses.
    Davies JA; Schwalbach LM
    J S Afr Vet Assoc; 2000 Sep; 71(3):144-7. PubMed ID: 11205161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of moxidectin and ivermectin against hypobiotic and encysted cyathostomes and other equine parasites.
    Xiao L; Herd RP; Majewski GA
    Vet Parasitol; 1994 May; 53(1-2):83-90. PubMed ID: 8091622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky.
    Lyons ET; Tolliver SC; Kuzmina TA; Collins SS
    Parasitol Res; 2010 Nov; 107(6):1495-8. PubMed ID: 20714749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cylicocyclus species predominate during shortened egg reappearance period in horses after treatment with ivermectin and moxidectin.
    van Doorn DC; Ploeger HW; Eysker M; Geurden T; Wagenaar JA; Kooyman FN
    Vet Parasitol; 2014 Dec; 206(3-4):246-52. PubMed ID: 25458565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for high endoparasitic burden and the efficiency of a single anthelmintic treatment of Danish horses.
    Larsen MM; Lendal S; Chriél M; Olsen SN; Bjørn H
    Acta Vet Scand; 2002; 43(2):99-106. PubMed ID: 12173507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of different genotype larvae and adult worms for anthelmintic resistance by persistent and short-acting avermectin/milbemycins.
    Barnes EH; Dobson RJ; Stein PA; Le Jambre LF; Lenane IJ
    Int J Parasitol; 2001 May; 31(7):720-7. PubMed ID: 11336754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.